INTRAVENOUS GLUTATHIONE THERAPY
Glutathione (GSH) is the body’s major systemic anti-toxin, antioxidant, and free-radical scavenger. In fact the ratio of reduced Glutathione to oxidized Glutathione is one of the most accurate indicators of cellular health. This makes this valuable nutrient vital for protecting cells from damage as well as for detoxifying biotoxins and toxic heavy metals. The liver has the highest concentration of GSH in the body which makes sense since the liver is the most important organ of detoxification in the body. Unfortunately, with aging, nutrient deficiencies, toxicities, and infections, GSH can be drastically reduced, leaving the body vulnerable to the ill effects of damaging substances. Oral GSH is very poorly absorbed, therefore, the most effective method of increasing GSH levels is to inject it intravenously.
Intravenous GSH has proven effective in the treatment of hypercoagulating blood disorders, jaundice caused by liver disease, and anemia. It plays a critical role in toxic metal transport, storage, and metabolism, therefore, acting to clear these lethal toxins from the body. With accurate testing toxic metals are found to be elevated in most people today. They contribute to many chronic degenerative diseases, particularly heart disease, neurological disease, and inflammatory conditions. GSH also safely removes biotoxins from the body via the liver.
Although GSH is vital to liver detoxification, it also acts as the major detoxifier of the kidneys, lungs, intestines, and all other organs systems in the body. It is vital to immune function and stimulates both B and T-cell growth and proliferation which act to protect from invading micro-organisms and toxins. GSH moderates the immune system helping to regulate both an over stimulated (allergy, asthma, eczema, auto-immunity etc) and an under stimulated or sluggish (chronic infections, fatigue, fever etc) immune system.
Conditions which can benefit from IV GSH therapy are Neurological disorders including but not limited to: Parkinson’s disease, Alzheimer’s, ALS, Stroke, Epilepsy, Cerebral trauma, ADD and Autism. It also has shown benefit in toxic conditions such as Chronic Fatigue Syndrome, Lyme disease, Fibromyalgia, and Chronic infections. GSH is highly protective of the brain. In one study with Parkinson’s patients, GSH was shown to be reduced by 40-50% in the part of the brain affected by Parkinson’s called the Substantia nigra.
Others methods of increasing GSH levels include eating a high protein, low carbohydrate diet, consuming bioactive goat or bovine whey protein regularly, and by increasing tissue levels of zinc, magnesium, selenium, vitamin E, carnosine, B-vitamins, milk thistle, alpha-lipoic-acid, N-acetyl-cysteine and melatonin. GSH tissue levels are depleted by petrochemicals, Tylenol (acetaminophen), alcohol, environmental toxins, household chemicals, toxic metals, and infections.
Intavenous GSH is administered from twice weekly to once monthly depending on the patient’s condition and its severity. It is often administered along with IV phophatidylcholine (Plaque therapy) in a treatment called Phospholipid Exchange to further enhance detoxification and cellular revitalization.